Replies to post #3832 on THE WOOF OF WALL STREET

[BottomBounce]

$CLDC China Lending Corporation, formerly DT Asia Investments Limited, is engaged in providing loan facilities to micro, small and medium sized enterprises (MSMEs), and proprietors in the Xinjiang Uyghur Autonomous Region (Xinjiang Province) of the People's Republic of China. The Company offers loans to industries, including commerce, service, supply chain finance, manufacturing, real estate, mineral and energy, and others. Its subsidiaries include Adrie Global Holdings Limited (Adrie), Feng Hui Ding Xin (Beijing) Financial Consulting Co., Limited (Consulting) and Xinjian Feng Hui Jing Kai Direct Lending Limited (XWFOE). Adrie is a holding company that has no operations and no assets, and has ownership in Feng Hui Financial Group. Consulting is engaged in the business of providing risk management-related financial consulting services to third-party direct lending companies in China. XWFOE is focused on providing direct loans to MSMEs and proprietors in Xinjiang Province.

[BottomBounce]

$INSY Insys Therapeutics, Inc., a specialty pharmaceutical company, develops and commercializes supportive care products. The company markets SUBSYS, a sublingual fentanyl spray for breakthrough cancer pain in opioid-tolerant adult patients; and SYNDROS, an orally administered liquid formulation of dronabinol for the treatment of chemotherapy-induced nausea and vomiting, and anorexia associated with weight loss in patients with AIDS. It is also developing Cannabidiol Oral Solution, which has completed pediatric study for the treatment of pediatric epilepsy; has completed Phase II study to treat west syndrome; and is in Phase II study for the treatment of childhood absence epilepsy, as well as Buprenorphine Sublingual Spray that has completed Phase III study to treat acute pain. In addition, the company is developing Cannabidiol Oral Solution for the treatment of prader willi; Buprenorphine/Naloxone Sublingual Spray to treat opioid dependence; and Naloxone Nasal Spray for the treatment of opioid antagonist. Insys Therapeutics, Inc. is headquartered in Chandler, Arizona

[BottomBounce]

$CLDC bounce play